Related Experiment Video
Updated: May 5, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Multifunctional Zwitterionic N-Oxide Polymers to Overcome Cascade Physiological Barriers for Efficient Anticancer
Moujiang Zheng1, Yufei Cao1, Qinghao Zhou1
1School of Chemistry, Xi'an Key Laboratory of Sustainable Polymer Materials, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, China.
None:
For efficient anticancer drug delivery, cascade physiological barriers must be overcome, which requires the drug delivery vehicles to possess different or even opposite properties at different stages. Poly(tertiary amine-oxide) (PTAO) polymers with the zwitterionic feature have distinct antifouling properties in blood circulation, which can be reduced and protonated in hypoxic tumors to promote cellular internalization. Nevertheless, the effects of various PTAO structures have not been studied systemically and optimized. In this report, the side groups of PTAO are proposed to be optimized by modulating the structures. Poly(2-(N-oxide-hexamethyleneimino)ethyl methacrylate) (POC7A) with a cyclic seven-membered ring is screened as the optimized PTAO structure for in vivo applications. Moreover, the block copolymer POC7A-block-poly(ε-caprolactone) (POC7A-PCL) is prepared for the formation of micelles in aqueous solution for delivery of doxorubicin (DOX). The zwitterionic nature of POC7A shells with efficient bioreductive activity and protonation in the tumor microenvironment endows the micelles with excellent antifouling properties for long blood circulation, efficient tumor accumulation, deep penetration, and effective cellular internalization. Thus, the DOX-loaded micelles exhibit potent antitumor efficacy after intravenous administration. Zwitterionic POC7A can be used as antifouling shells of the anticancer drug delivery nanocarriers to overcome the cascade physiological barriers efficiently.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Modified-Release Drug Delivery Systems: Rate-Programmed II
Drug Delivery Systems: Different Types
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers

